These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 12695721)

  • 1. Cardiovascular mortality in end-stage renal disease.
    Collins AJ
    Am J Med Sci; 2003 Apr; 325(4):163-7. PubMed ID: 12695721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-recovery from dialysis-requiring acute kidney injury and short-term mortality and cardiovascular risk: a cohort study.
    Lee BJ; Hsu CY; Parikh RV; Leong TK; Tan TC; Walia S; Liu KD; Hsu RK; Go AS
    BMC Nephrol; 2018 Jun; 19(1):134. PubMed ID: 29890946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of aortic stiffness on survival in end-stage renal disease.
    Blacher J; Guerin AP; Pannier B; Marchais SJ; Safar ME; London GM
    Circulation; 1999 May; 99(18):2434-9. PubMed ID: 10318666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Cardiovascular Events on End-Stage Renal Disease and Mortality in Patients With Chronic Kidney Disease Before Dialysis.
    Kuwahara M; Takehara E; Sasaki Y; Azetsu H; Kusaka K; Shikuma S; Akita W
    Ther Apher Dial; 2016 Feb; 20(1):12-9. PubMed ID: 26679409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular factors influencing survival in dialysis patients.
    Alpert MA
    Adv Perit Dial; 1996; 12():110-9. PubMed ID: 8865884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between Kidney Length and Cardiovascular and Renal Risk in High-Risk Patients.
    van der Sande NGC; Visseren FLJ; van der Graaf Y; Nathoe HM; de Borst GJ; Leiner T; Blankestijn PJ;
    Clin J Am Soc Nephrol; 2017 Jun; 12(6):921-928. PubMed ID: 28487344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do children with end-stage renal disease live shorter? Analysis of mortality on the basis of data from the Polish Registry of Renal Replacement Therapy in Children.
    Zagożdżon I; Żurowska A; Prokurat S; Rubik J; Drożdż D; Szczepańska M; Warzywoda A; Jander A; Ziółkowska H; Makulska I; Bieniaś B; Kipigroch H; Wierciński R; Siteń G
    Adv Med Sci; 2015 Mar; 60(1):13-7. PubMed ID: 25194453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial microvascular disease and major adverse cardiovascular events in patients with end-stage renal disease: rationale and design of the MICROCARD study.
    Bejan-Angoulvant T; Bergerot C; Juillard L; Mezergues A; Morelon E; Pouteil-Noble C; André-Fouët X; Angoulvant D
    Nephrol Dial Transplant; 2012 Jul; 27(7):2886-91. PubMed ID: 22344775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology: The global burden of reduced GFR: ESRD, CVD and mortality.
    Sharma S; Sarnak MJ
    Nat Rev Nephrol; 2017 Aug; 13(8):447-448. PubMed ID: 28626221
    [No Abstract]   [Full Text] [Related]  

  • 11. Familiality of cardiovascular mortality in end-stage renal disease patients.
    Naiman N; Cheung AK; Goldfarb-Rumyantzev AS
    Am J Nephrol; 2009; 29(3):237-43. PubMed ID: 18799871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular disease and atherosclerosis in uremia.
    London GM
    Nefrologia; 2005; 25 Suppl 2():91-5. PubMed ID: 16050410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement.
    Gupta T; Goel K; Kolte D; Khera S; Villablanca PA; Aronow WS; Bortnick AE; Slovut DP; Taub CC; Kizer JR; Pyo RT; Abbott JD; Fonarow GC; Rihal CS; Garcia MJ; Bhatt DL
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2050-2060. PubMed ID: 29050621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of cardiovascular events in end-stage renal disease patients with osteoporosis: a nationwide population-based cohort study.
    Yu TM; Lin CL; Shu KH; Liu YL; Chen CH; Huang ST; Kao CH
    Osteoporos Int; 2015 Feb; 26(2):785-93. PubMed ID: 25491767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peritoneal dialysis and cardiopulmonary comorbidity].
    Wiesholzer M
    Wien Klin Wochenschr; 2005; 117 Suppl 6():46-53. PubMed ID: 16437333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing cardiovascular disease in the dialysis patient.
    Baig SZ; Coats WC; Aggarwal KB; Alpert MA
    Adv Perit Dial; 2009; 25():147-54. PubMed ID: 19886337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
    Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
    Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of cardiac mortality in patients with new-onset end-stage renal disease in New York State.
    Wallen MD; Radhakrishnan J; Appel G; Hodgson ME; Pablos-Mendez A
    Clin Nephrol; 2001 Feb; 55(2):101-8. PubMed ID: 11269672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?
    Raggi P; Boulay A; Chasan-Taber S; Amin N; Dillon M; Burke SK; Chertow GM
    J Am Coll Cardiol; 2002 Feb; 39(4):695-701. PubMed ID: 11849871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of vascular disease in renal failure.
    Ikizler TA
    Blood Purif; 2002; 20(1):6-10. PubMed ID: 11803153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.